Subscribe to our Newsletters !!
Although copying the blueprint is extremely comple
Eppendorf introduces a new addition to their Eppen
The recent rabies death of an 11 year old Canadian
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
Generic medicines have become a cornerstone in hea
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to the latest issue of Micro
Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia’s Vector Institute, the RIA news agency mentioned Russian customer safety watchdog Rospotrebnadzor as saying on Wednesday
The institute completed early-stage human trials, known as Phase II, earlier this month.
